FDA Takes ‘Significant Action’ to Ramp Up Ventilator and Respiratory Device Supply

An employee of Hamilton Medical AG tests a ventilator at a plant in Domat/Ems, Switzerland, on March 18, 2020. Reuters/Arnd Wiegmann/File Photo

The Food and Drug Administration (FDA) says it has taken “significant action” to increase the availability of respiratory devices, including ventilators, in the fight against the COVID-19 pandemic.

“The FDA’s new actions will mean America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a statement.